Journal
DEVELOPMENT
Volume 143, Issue 9, Pages 1435-1441Publisher
COMPANY BIOLOGISTS LTD
DOI: 10.1242/dev.133652
Keywords
Cardiomyocyte; Heart; Regenerative medicine; Stem cells
Categories
Funding
- British Heart Foundation [RG/15/1/31165, CH/08/002, RE/13/4/30184, RM/13/1/30157, RG/08/007/25296] Funding Source: Medline
- Medical Research Council [G0901467] Funding Source: Medline
- Wellcome Trust [WT10638] Funding Source: Medline
- British Heart Foundation [RG/08/007/25296, RG/15/1/31165] Funding Source: researchfish
- Medical Research Council [G0901467] Funding Source: researchfish
- MRC [G0901467] Funding Source: UKRI
Ask authors/readers for more resources
In February 2016, The Company of Biologists hosted an intimate gathering of leading international researchers at the forefront of experimental cardiovascular regeneration, with its emphasis on 'Transdifferentiation and Tissue Plasticity in Cardiovascular Rejuvenation'. As I review here, participants at the workshop revealed how understanding cardiac growth and lineage decisions at their most fundamental level has transformed the strategies in hand that presently energize the prospects for human heart repair.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
